Authors
Latest:
Multiple Sclerosis Palliative Care Spikes in United StatesThe rate of palliative care in patients with multiple sclerosis to have died in US hospitals increased from 7.7% to 58.8% over 10 years
Latest:
Hepatitis C: A Comprehensive Overview of Effective Treatment OptionsMany new antiviral drugs that treat hepatitis C have similar efficacy, but come with different advantages and disadvantages.
Latest:
Incentive Formularies: Spending and Utilization for 3 Common Drug ClassesIncentive formularies with varying cost sharing led to modestly lower overall spending, with savings for plan sponsors offset by increased out-of-pocket spending.
Latest:
Diabetes Drug Label Includes New RisksWarnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.
Latest:
Rheumatoid Arthritis and Joint Replacement: Impact of BiologicsSince the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Latest:
Pharmacogenomics, Enzyme Competition, and the Evolution of Precision PrescribingIt is understood that a person’s genetics determines traits such as eye, hair, and skin color and even the predisposition to contracting certain diseases.
Latest:
Effectiveness and Costs of Biologics in Veterans With Rheumatoid ArthritisThis study applied a validated algorithm to estimate the effectiveness and costs of the index biologic used by 4696 US veterans with rheumatoid arthritis.
Latest:
The Impact of Telemedicine on Pharmacists and Implications for Controlled SubstancesTo better accommodate this significant portion of the population, a new form of health care has broken through to redefine the nature of medici- nal services: telehealth.
Latest:
Motivational Interviewing: Effective Communication Is VitalThis overlooked skill can help determine which issues should be passed on to the pharmacist.
Latest:
Varied Cultural Experiences Help Inform PharmacistsI learned myriad life and professional lessons from my travels.
Latest:
Connecting the Dots for a Digital Deploy: A Guide to Engaging Pharma StakeholdersStrategic tips for pharma to develop an overall business strategy around digital engagement.
Latest:
Express Scripts' Acquisition of Medco: Are There Two Sides of the Coin for Independents?Guest blogger George Van Antwerp argues that although PBMs may complicate pharmacists' lives, there is an opportunity to make lemonade out of lemons.
Latest:
Biosimilars and Follow-on BiologicsPharmacists must be experts on follow-on biologics (FOBs), including biosimilars, so they can provide education to health professionals about safe prescribing and use, which ultimately affects patient care.
Latest:
The Business Case: Formal Adherence Service in the Community PharmacyA business model focused on medication synchronization can boost adherence and profits.
Latest:
Going Above and Beyond as PharmacistsLearn more about what it's like to work for a Walgreens specialty pharmacy.
Latest:
Emerging Therapies for Hemophilia A and BAlthough the leading treatment for hemophilia is a replacement therapy in the form of both plasma-derived and rF products, research is underway for the discovery of novel agents.
Latest:
Wake-Up Call: Engaging the Pharmacist in Individualizing Treatment and Optimizing Patient Outcomes in InsomniaThis Continuing Education activity is supported by an educational grant from Merck Sharp & Dohme Corp.
Latest:
A Closer Look at New FDA Actions: Amgen's ProliaAmgen Inc's new monoclonal antibody Prolia (denosumab) is the first "biologic therapy" approved by the FDA for the treatment of osteoporosis in menopausal women.
Latest:
Implementation Strategy to Bring Medication Therapy Management Into High-ÂVolume Community PharmaciesThis study shows how medication therapy management can be integrated into challenging pharmacy work flow, and also assesses the resulting benefits, both clinical and financial.
Latest:
Pharmacotherapy Timing in Heart Failure and Impact on Healthcare CostsThe findings of a retrospective study suggest that timing of heart failure (HF)-related pharmacotherapy following a HF-related encounter has potential implications on subsequent healthcare costs.
Latest:
HHS Issues Much Anticipated Updates to Provider Relief Fund Deadlines and Reporting RequirementsPharmacies that received more than $750,000 in federal funds, including funds from the CARES Act Provider Relief Fund, will be subject to single audit requirements.
Latest:
Annual Stroke Costs to Health Plans Among Atrial Fibrillation PatientsAn incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
